DPYSL2 and non-small cell lung carcinoma: For that purpose, we generated CRMP2 phosphomutant clones by stably transfecting A549 and H1299 NSCLC cells with plasmid vectors expressing CRMP2 Ser522 phosphorylation mimetic (S522D) and phosphorylation-resistant (S522A) mutants.